Davenport & CO LLC Amgen Inc Call Options Transaction History

Davenport & CO LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 06, 2024	BUY	$262.75 - $319.31 $52,550 - $63,862	200 Added 2.78%	7,400 $2.31 Million
Q4 2023 Jan 23, 2024	BUY	$255.7 - $288.46 $51,140 - $57,691	200 Added 2.86%	7,200 $2.07 Million
Q3 2023 Oct 17, 2023	BUY	$218.65 - $271.46 $21,865 - $27,145	100 Added 1.45%	7,000 $1.88 Million
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $21,427 - $25,337	100 Added 1.47%	6,900 $1.53 Million
Q1 2023 Apr 27, 2023	BUY	$225.79 - $275.2 $22,579 - $27,520	100 Added 1.49%	6,800 $1.64 Million
Q4 2022 Jan 20, 2023	BUY	$229.03 - $291.01 $22,903 - $29,101	100 Added 1.52%	6,700 $0
Q3 2022 Oct 11, 2022	BUY	$224.46 - $253.15 $22,446 - $25,315	100 Added 1.54%	6,600 $1.49 Million
Q2 2022 Jul 18, 2022	BUY	$230.71 - $256.74 $23,071 - $25,674	100 Added 1.56%	6,500 $1.58 Million
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $65,781 - $72,771	300 Added 4.92%	6,400 $1.55 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $1.21 Million - $1.39 Million	6,100 New	6,100 $1.37 Million

3,082

417M

7.24M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.